BioSpace News Archive

Business

Reata Pharmaceuticals, Inc. to Report Third Quarter 2021 Financial Results and to Provide an Update on Development Programs on November 8, 2021

Reata Pharmaceuticals, Inc. today announced that it will report financial results and provide an update on recent progress on its development programs pre-market on November 8, 2021.

November 1, 2021
·
1 min read
BioNTech to Present New Clinical Data from First-in-Class CAR-T Program BNT211 in Late-breaking Session at 36th SITC Annual Meeting

BioNTech SE today announced that new clinical data from the first-in-human Phase 1/2 trial evaluating the Company’s novel CAR-T cell therapy candidate, BNT211, will be presented in an oral presentation.

November 1, 2021
·
2 min read
BioCapital

NextCure to Host Virtual Oncology Pipeline Update Event on November 15, 2021

NextCure, Inc. today announced that the company will host a Virtual Oncology Pipeline Update Event at 4:30 p.m. ET on Monday, November 15, 2021.

November 1, 2021
·
3 min read
Business

Science 37 to Report Third Quarter 2021 Financial Results on November 15, 2021

Science 37 Holdings, Inc. today announced it will report third quarter 2021 financial results before the market opens on Monday, November 15, 2021.

November 1, 2021
·
1 min read
Business

F-star Therapeutics to Announce Third Quarter Results and Host Conference Call on November 10, 2021

F-star Therapeutics, Inc. announced today that the Company will hold a conference call and webcast on November 10, 2021, at 9:00 a.m. EST to review third quarter 2021 financial results and provide a corporate update.

November 1, 2021
·
1 min read
BioForest

Cocrystal Pharma Submits Pre-Investigational New Drug Briefing Package to the FDA for Clinical Development Guidance of CDI-45205 for COVID-19 Treatment

Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces the submission of a pre-Investigational New Drug (IND) briefing package to the U.S. Food and Drug Administration (FDA) for its broad-spectrum protease inhibitor CDI-45205

November 1, 2021
·
4 min read
Business

ANI Pharmaceuticals Reports Third Quarter 2021 Results

ANI Pharmaceuticals, Inc. announced business highlights and financial results for the three months ended September 30, 2021.

November 1, 2021
·
13 min read
Bio NC

Asensus Surgical Announces Shinmatsudo Central General Hospital in Japan to Initiate Senhance Robotic Surgical System

Asensus Surgical, Inc. today announced the Shinmatsudo Central General Hospital in Matsudo, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System.

November 1, 2021
·
4 min read
Arecor Announces An Exclusive Formulation Study Collaboration With A Leading Global Medical Products Company To Develop A Stable Ready To Administer Product

Arecor Therapeutics plc announces that it has signed an exclusive formulation study collaboration with a leading global medical products company.

November 1, 2021
·
2 min read
FDA

Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 Gangliosidosis

Sio Gene Therapies Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to AXO-AAV-GM2, an investigational gene therapy for the treatment of early infantile, late infantile, and juvenile-onset Tay-Sachs and Sandhoff disease.

November 1, 2021
·
6 min read